Xencor reported $-38348000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US USD 4.6B 1.31B
Alnylam Pharmaceuticals ALNY:US USD -334626000 142.94M
Amgen AMGN:US USD 2.74B 562M
Arrowhead Research ARWR:US USD -72909000 114.46M
AstraZeneca AZN:LN USD 1.25B 706M
Biogen BIIB:US USD 1.32B 1.37B
Bristol Myers Squibb BMY:US USD 2.47B 117M
Cytokinetics CYTK:US USD -130687000 119.81M
GlaxoSmithKline GSK:LN GBP 1.19B 110M
Johnson & Johnson JNJ:US USD 5.82B 18M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Merk MRK:US USD 3.99B 939M
Novartis NOVN:VX USD 2.17B 60M
Pfizer PFE:US USD 9.41B 2.69B
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M
Seattle Genetics SGEN:US USD -192805000 59.69M
Xencor XNCR:US USD -38348000 10.35M